- Home
- NYC vs AEON Comparison
NYC vs AEON Comparison
Compare NYC & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.13
Company Overview
Basic Information| Metric | NYC | AEON |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5M | 26.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | NYC | AEON |
|---|---|---|
| Price | $8.12 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 1.7K | ★ 79.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.40 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.03 | $0.38 |
| 52 Week High | $16.30 | $1.45 |
Technical Indicators
Market Signals| Indicator | NYC | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 50.63 |
| Support Level | $7.12 | $0.69 |
| Resistance Level | $8.28 | $1.42 |
| Average True Range (ATR) | 0.31 | 0.10 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 7.81 | 36.97 |
Price Performance
Historical Comparison NYC
AEON
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.